|
|
|
Volumn 2, Issue 1, 2000, Pages 40-46
|
|
Sterol biosynthesis inhibitors for Chagas' disease
|
|
Author keywords
Chagas' disease; Sterol biosynthesis inhibitors; Trypanosoma cruzi
|
|
Indexed keywords
2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL;
2 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 4 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL] 1,2,4 TRIAZOL 3(2H) ONE;
ALBACONAZOLE;
BENZNIDAZOLE;
KETOCONAZOLE;
NIFURTIMOX;
POSACONAZOLE;
RAVUCONAZOLE;
TRIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANOREXIA;
ANTIFUNGAL ACTIVITY;
ANTIPROTOZOAL ACTIVITY;
CHAGAS DISEASE;
DISEASE MODEL;
DOSE RESPONSE;
DRUG HALF LIFE;
DRUG POTENCY;
HUMAN;
MOUSE;
NONHUMAN;
POLYNEUROPATHY;
RABBIT;
RAT;
REVIEW;
SKIN DISEASE;
TRYPANOSOMA CRUZI;
VOMITING;
|
|
EID: 0034104491
PISSN: 14648458
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (21)
|
|
References (60)
|
